Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

GRI stock hub

GRI Bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GRIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GRI

In the news

Latest news · GRI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-238.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-146.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GRI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001824293
Company name	GRI Bio, Inc.
Country	United States
Country code	US
Cusip	3622AW502
Employees	4
Employees Change	3%
Employees Change Percent	300
Enterprise value	$-4.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US3622AW5029
Last refreshed	2026-05-10
Market cap	$3.2M
Market cap category	Nano-Cap
Price	$2.25
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	GRI
Website	https://www.gribio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-368.55%
FCF yield	-314.08%
P/B ratio	0.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-12M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-3M
ROA	-103.9
Roa5y	-266.3
ROCE	-198.9
ROE	-238.2
ROIC	-146.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-95.53%
Cagr3y	-98.05%
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.7M
Cash	$8.2M
Current Assets	$8.6M
Current Liabilities	$2.6M
Debt	$71,000
Debt Equity	$0.01
Equity	$6M
Liabilities	$2.7M
Long Term Assets	$74,000
Long Term Liabilities	$15,000
Net Cash	$8.2M
Net Cash By Market Cap	$251
Net Cash Growth	66.18%
Net Debt Equity	$-1.36
Tangible Book Value	$6M
Tangible Book Value Per Share	$12.07
WACC	0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.25
Net Working Capital	$-2.2M
Quick ratio	3.11
Working Capital	$5.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-95.52%
200-day SMA	26.15
3Y total return	-100%
50-day SMA	2.44
50-day SMA vs 200-day SMA	50under200
All Time High	577,401.2
All Time High Change	-100%
All Time High Date	2023-04-24
All Time Low	2.1
All Time Low Change	6.9%
All Time Low Date	2026-02-12
ATR	0.18
Beta	-0.77
Beta1y	1.99
Beta2y	2.46
Ch YTD	-67.51
High	2.32
High52	80.36
High52 Date	2025-09-11
High52ch	-97.21%
Low	2.23
Low52	2.1
Low52 Date	2026-02-12
Low52ch	6.91%
Ma50ch	-7.84%
Price vs 200-day SMA	-91.41%
RSI	41.25
RSI Monthly	3.87
RSI Weekly	22.13
Sharpe ratio	-1.69x
Sortino ratio	-1.98
Tr YTD	-67.51
Tr1m	-2.39%
Tr1w	2.98%
Tr3m	-6.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-3.17
Operating Income	$-12M
Price target	$160
Price Target Change	$7,027

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,445,027%
Float Percent	100%
Shares Insiders	0%
Shares Institutions	0.71%
Shares Out	1,445,029
Shares Qo Q	114.34%
Short Float	9.3%
Short Ratio	0.88
Short Shares	9.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11M
Average Volume	47,126.7x
Bv Per Share	12.07
CAPEX	$-3,000
Ch1m	-2.39
Ch1w	2.98
Ch1y	-95.52
Ch3m	-6.07
Ch3y	-100
Ch6m	-95.23
Change	-0.22%
Change From Open	-2.39
Close	2.25
Days Gap	2.22
Depreciation Amortization	4,000
Dollar Volume	40,960
Earnings Date	2026-05-15
Earnings Time	bmo
EBIT	$-12M
EBITDA	$-12M
EPS	$-122
F Score	1
FCF	$-10.2M
FCF EV Yield	207.35x
FCF Per Share	$-7.05
Financing CF	13,390,000
Fiscal Year End	December
Founded	2,018
Investing CF	-3,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-01-30
Last Report Date	2025-12-31
Last Split Date	2026-01-26
Last Split Type	Reverse
Last10k Filing Date	2026-01-30
Ma150	19.6
Ma150ch	-88.54%
Ma20	2.38
Ma20ch	-5.47%
Net CF	3,201,000
Next Earnings Date	2026-05-22
Open	2.3
Optionable	No
Position In Range	16.67
Post Close	2.25
Postmarket Change Percent	5.57
Postmarket Price	$2.37
Ppne	74,000
Price Date	2026-05-08
Ptbv Ratio	0.54
Relative Volume	0.39x
Share Based Comp	793,000
Tr6m	-95.23%
Us State	California
Volume	18,245

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GRI pay a dividend?

Capital-return profile for this ticker.

Performance

GRI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GRI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Float: +100.0% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GRI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.2

Neutral momentum band

Price vs 200-day MA

-91.4%

50/200-day relationship not available

Beta (5Y)

-0.77

Less volatile than the market

Sharpe ratio

-1.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GRI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GRI stock rating?

GRI Bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GRI analysis?

The full report lives at /stocks/GRI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GRI?

The latest report frames GRI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GRI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.